You have 9 free searches left this month | for more free features.

idarubicin

Showing 1 - 25 of 141

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)

Terminated
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 1, 2021

Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia (Relapsed/Refractory)
  • Frankfurt am Main, Hessen, Germany
  • +2 more
Aug 1, 2021

Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))

Completed
  • Myelodysplastic Syndrome
  • Acute Myeloid Leukemia
  • Idarubicin
  • +2 more
  • Tampa, Florida
  • +1 more
Dec 1, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Terminated
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

Recruiting
  • AML, Adult
  • Chemotherapy Effect
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Feb 28, 2022

APL Trial in Valencia (Atra, Idarubicin, methotrexate)

Recruiting
  • APL
  • Valencia, Spain
    Hospital La Fe
Mar 22, 2021

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute

Recruiting
  • Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2021

Liver Cancer Trial in France (idarubicin, Dc- Beads 300-500µm)

Completed
  • Liver Cancer
  • idarubicin
  • Dc- Beads 300-500µm
  • Amiens, France
  • +6 more
Mar 27, 2020

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +4 more
Aug 3, 2022

Acute Myeloid Leukemia Trial in Lanzhou (Venetoclax, Azacitidine, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Lanzhou, Gansu, China
    Long Zhao
Apr 24, 2022

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage Trial in Houston (Clofarabine,

Recruiting
  • Acute Bilineal Leukemia
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Myeloid Leukemia Trial in Augusta, Baltimore (Idarubicin, Cytarabine, Indoximod Freebase)

Completed
  • Acute Myeloid Leukemia
  • Idarubicin
  • +4 more
  • Augusta, Georgia
  • +1 more
Jun 3, 2020

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Acute Myeloid Leukemia Trial in Tokyo (Quizartinib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Tokyo, Japan
    (unnamed)
Jul 26, 2021

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 14, 2019

AML in Remission Trial in Fuzhou (Idarubicin, ID cytarabine)

Recruiting
  • AML in Remission
  • Idarubicin
  • ID cytarabine
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jan 1, 2020

Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Cyclophosphamide, Dexamethasone, Vincristine)

Completed
  • Adult Acute Lymphocytic Leukemia
  • Frankfurt, Germany
    University of Frankfurt, Medical Dept. II
Aug 17, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Cytarabine, Idarubicin, Etoposide)

Completed
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +43 more
Dec 29, 2020

Core Binding Factor Acute Myeloid Leukemia Trial in Guangzhou (Sorafenib, Idarubicin, Cytarabine)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
May 31, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Frankfurt (Main) (Rituximab, Nelarabine, PEG-Asparaginase)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Frankfurt (Main), Germany
    University Hospital of Frankfurt (Main)
Jul 1, 2022